These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 9402590)
1. Systemic administration of the iron chelator deferiprone attenuates subarachnoid hemorrhage-induced cerebral vasospasm in the rabbit. Arthur AS; Fergus AH; Lanzino G; Mathys J; Kassell NF; Lee KS Neurosurgery; 1997 Dec; 41(6):1385-91; discussion 1391-2. PubMed ID: 9402590 [TBL] [Abstract][Full Text] [Related]
2. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm. Wanebo JE; Arthur AS; Louis HG; West K; Kassell NF; Lee KS; Helm GA Neurosurgery; 1998 Dec; 43(6):1409-17; discussion 1417-8. PubMed ID: 9848855 [TBL] [Abstract][Full Text] [Related]
3. A study of the effectiveness of the iron-chelating agent deferoxamine as vasospasm prophylaxis in a rabbit model of subarachnoid hemorrhage. Vollmer DG; Hongo K; Ogawa H; Tsukahara T; Kassell NF Neurosurgery; 1991 Jan; 28(1):27-32. PubMed ID: 1994279 [TBL] [Abstract][Full Text] [Related]
4. The novel 5-lipoxygenase inhibitor ABT-761 attenuates cerebral vasospasm in a rabbit model of subarachnoid hemorrhage. Barbosa MD; Arthur AS; Louis RH; MacDonald T; Polin RS; Gazak C; Kassell NF Neurosurgery; 2001 Nov; 49(5):1205-12; discussion 1212-3. PubMed ID: 11846914 [TBL] [Abstract][Full Text] [Related]
5. Systemic administration of the potassium channel activator cromakalim attenuates cerebral vasospasm after experimental subarachnoid hemorrhage. Kwan AL; Lin CL; Yanamoto H; Howng SL; Kassell NF; Lee KS Neurosurgery; 1998 Feb; 42(2):347-50; discussion 350-1. PubMed ID: 9482186 [TBL] [Abstract][Full Text] [Related]
6. Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage. Matsuda N; Ohkuma H; Naraoka M; Munakata A; Shimamura N; Asano K J Neurosurg; 2014 Sep; 121(3):621-30. PubMed ID: 24949677 [TBL] [Abstract][Full Text] [Related]
17. Oral administration of an inhibitor of endothelin-converting enzyme attenuates cerebral vasospasm following experimental subarachnoid haemorrhage in rabbits. Kwan AL; Lin CL; Chang CZ; Winardi D; Yen CP; Wu SC; Lee KS; Kassell NF; Howng SL; Savage P; Jeng AY Clin Sci (Lond); 2002 Aug; 103 Suppl 48():414S-417S. PubMed ID: 12193135 [TBL] [Abstract][Full Text] [Related]
18. The effect of thiocolchicoside on cerebral vasospasm following experimental subarachnoid hemorrhage in the rabbit. Kertmen H; Gürer B; Yilmaz ER; Arikok AT; Demirci A; Gökyaprak SM; Sekerci Z Acta Neurochir (Wien); 2012 Aug; 154(8):1431-6. PubMed ID: 22722379 [TBL] [Abstract][Full Text] [Related]
19. Effect of remacemide hydrochloride on subarachnoid hemorrhage-induced vasospasm in rabbits. Zuccarello M; Lewis AI; Upputuri S; Farmer JB; Anderson DK J Neurotrauma; 1994 Dec; 11(6):691-8. PubMed ID: 7723068 [TBL] [Abstract][Full Text] [Related]
20. Attenuation of cerebral vasospasm by systemic administration of an endothelin-A receptor antagonist, TBC 11251, in a rabbit model of subarachnoid hemorrhage. Wanebo JE; Louis HG; Arthur AS; Zhou J; Kassell NF; Lee KS; Helm GA Neurosurg Focus; 1997 Oct; 3(4):ARTICLE. PubMed ID: 15104411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]